Skip to main content
. 2019 Feb 18;14:447–456. doi: 10.2147/COPD.S191031

Table 2.

Exacerbation costs in France

Total costs Moderate exacerbation Severe exacerbation
National Sickness Fund perspective (below retirement age of 62 years) €801 €7,504a
National Sickness Fund perspective (above retirement age of 62 years) €801 €7,438
Societal perspective (below retirement age of 62 years) €1,341b €9,362c
Societal perspective (above retirement age of 62 years) €866 €8,037

Notes: Data from Laurendeau et al.16

a

Costs from Laurendeau et al’s study + (4.81–3 first days not paid=) 1.81 × daily allowances of €36.45 per day.

b

Societal costs based on Laurendeau et al’s study + productivity loss as observed in the POET trial (1.73 days lost for a moderate exacerbation) multiplied with the costs of one day lost, €274.80.22,23

c

Societal costs based on Laurendeau et al’s study + productivity loss as observed in the POET trial (4.82 days lost for severe exacerbation), multiplied with the costs of 1 day lost, €274.80.22,23